Remove DNA Remove Genetics Remove Pharmacy
article thumbnail

23andMe makes $400m telehealth play, gulping down Lemonaid

pharmaphorum

Consumer DNA testing company 23andMe has signed a deal to acquire privately-held Lemonaid Health in a $400 million deal that marks a move into the online health sector. The transaction is expected to close before the end of the year.

DNA 111
article thumbnail

Bacteriophages: the viruses that can actually be good for you

Pharmaceutical Technology

Local UK pharmacies are already reporting and forecasting future shortages of antibiotics to treat Strep A infections. Bacteria naturally develop resistance to antibiotics over time, through genetic mutation, horizontal gene transfer between bacteria, or because of selective pressure. Phages are lytic or temperate.

Bacteria 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Addressing Healthcare Challenges and Innovations with Pepperdine University’s Dr. Gary Mangiofico

XTalks

The disjointed interactions among insurers, managed care providers, pharmacy benefit managers and clinicians hinder efficient population health management and disease prevention. Dr. Mangiofico suggests leveraging AI to streamline these processes.

DNA 59
article thumbnail

Black History Month: Recognizing the Revolutionary Contributions of Black Individuals in Science

XTalks

Ball went on to study chemistry at the University of Washington, earning a bachelor’s degree in pharmaceutical chemistry, followed by a second degree in pharmacy two years later. The controversy continues over profits, privacy of genetic information extracted from the cells and racial inequities in access to research and healthcare.

article thumbnail

Covid-19 vaccine success bolsters nanoparticle drug delivery research

Pharmaceutical Technology

In an email to this news service, João Conde, PhD, professor at NOVA Medical School, Universidade NOVA de Lisboa, said advances like the mRNA vaccines serve as a testament to the breakthroughs made by science over decades of research at the junction of genetics and nanomedicine. These could feature in the next four to five years.

article thumbnail

COVID-19 Pandemic Coverage

XTalks

CanSino Biologics is developing a vaccine that involves snipping a bit of the virus’ genetic code off and coupling it with a harmless virus to provoke a SARS-CoV-2 immune response. Several laboratories have already shown that they can detect genetic material from the virus in wastewater.

Vaccine 92